XE (XE) Stock Price & Analysis

XE (XE) fell 8.88% to USD 20.43 as of June 10, 2026 at 01:58 UTC, according to Nexqual real-time market data.

XE last closed at USD 22.42; the session ranged USD 19.69–22.75 on volume of 4,142,213 shares. Market capitalization is $5.87B, with a 52-week range of USD 19.69–37.1 (NMS). Source: Nexqual, June 10, 2026 at 01:58 UTC.

Key Statistics (as of June 10, 2026 at 01:58 UTC)

PriceUSD 20.43
Change▼ 8.88% (down)
Previous CloseUSD 22.42
OpenUSD 22.45
Day RangeUSD 19.69 – 22.75
52-Week RangeUSD 19.69 – 37.1
Volume4,142,213 shares
Market Cap$5.87B
ExchangeNMS

Technical Analysis (XE)

Nexqual's technical model rates XE "NEUTRAL" based on 2 bullish and 3 bearish signals across 32 daily candles, as of June 10, 2026 at 01:58 UTC.

Overall SignalNEUTRAL
RSI (14)34.94 (neutral)
MACD-2.48 (negative)

Analyst Ratings (XE)

Wall Street analysts rate XE "Buy" based on 7 analysts, with a mean price target of USD 39.86 (range USD 30–57), per Nexqual as of June 10, 2026 at 01:58 UTC.

Consensus RatingBuy
Analyst Count7
Mean TargetUSD 39.86
High TargetUSD 57
Low TargetUSD 30
Buy / Hold / Sell6 / 2 / 0

Earnings (XE)

Next Earnings Date2026-08-14
EPS EstimateUSD -0.09
Revenue Estimate$25.10M

Source: Nexqual, June 10, 2026 at 01:58 UTC.

Financials & Fundamentals (XE)

Total Revenue$94.26M
Revenue Growth (YoY)+43.00%
Gross Margin-71.19%
Operating Margin-178.81%
Profit Margin+0.00%
ROE-60.15%
Debt / Equity2.76
Current Ratio14.53
Total Cash$763.84M
Total Debt$23.23M
Free Cash Flow$-237.95M

Source: Nexqual, June 10, 2026 at 01:58 UTC.

Financial Health Score (XE)

Nexqual rates XE's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 01:58 UTC.

GrowthStrong — Revenue +43% YoY (latest Q)
ProfitabilityCritical — Heavily loss-making — early-stage company
Balance SheetStrong — $764M cash vs $23M debt, net cash position
Cash FlowWeak — FCF negative: -$238M, burning cash
EfficiencyCritical — ROE -60%, ROA -11.9%

Ownership (XE)

Insider Ownership+45.16%
Institutional Ownership+7.96%
Shares Outstanding287.46M
Short % of Float+3.42%

Source: Nexqual, June 10, 2026 at 01:58 UTC.

Leadership (XE)

XE is led by J. Clay Sell (age 57), CEO & Director, per Nexqual as of June 10, 2026 at 01:58 UTC.

CEO & DirectorJ. Clay Sell (age 57)
Founder & Executive ChairmanKamal Seyed Ghaffarian (age 66)
Executive VP & CFODaniel Andrew Gross (age 54)
Senior VP & Chief Technology OfficerMartin van Staden

Major Backers & Investors (XE)

Notable institutional backers of XE include ARK Invest, Manager Directed Portfolios-Hood River Small-Cap Growth Fund, Fidelity, according to Nexqual as of June 10, 2026 at 01:58 UTC.

Active Investors

InvestorStake
ARK Invest1.41%
Manager Directed Portfolios-Hood River Small-Cap Growth Fund0.73%
Fidelity0.22%

Source: Nexqual, June 10, 2026 at 01:58 UTC.

Peers & Related Stocks

SymbolNamePriceChange
CBRSCerebras Systems Inc.USD 226.82▲ 12.84%
INFQInfleqtion, Inc.USD 13.71▼ 5.84%
XNDUXanadu Quantum Technologies LimUSD 12▼ 6.98%
NNENano Nuclear Energy Inc.USD 23.94▲ 1.61%
QNTQuantinuum Inc.USD 54.94▼ 2.35%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 01:58 UTC. This page is informational and not investment advice.